Strategic CMO Partnership
Trusted manufacturing partnerships in China.
Through its CMO model, Kenvet Afri Limited engages multiple GMP-certified veterinary pharmaceutical manufacturers in China for the production of its product portfolio.
Company Overview
Kenvet Afri Limited is an emerging veterinary pharmaceutical enterprise headquartered in Nairobi, Kenya, with operational footprints across East Africa and China.
Kenvet Afri Limited is dedicated to the research, development, and supply of high-quality veterinary medicines, feed additives, and animal health solutions for livestock, poultry, companion animals, and aquaculture.
Leveraging a strategic Contract Manufacturing Organization (CMO) model, Kenvet Afri Limited collaborates with globally recognized manufacturing partners in China, while maintaining a strong local presence in Kenya to ensure regulatory compliance, supply chain reliability, and market accessibility across Africa.
Strategic CMO Partnership
Through its CMO model, Kenvet Afri Limited engages multiple GMP-certified veterinary pharmaceutical manufacturers in China for the production of its product portfolio.
Operations in Kenya
In Kenya, Kenvet Afri Limited operates a distribution and regulatory affairs hub to serve the East African veterinary market.
China CMO Coverage
Sourcing of high-potency veterinary APIs including florfenicol, tilmicosin, enrofloxacin, toltrazuril, oxytetracycline, penicillins, doxycycline, and dexamethasone from facilities equipped with 14+ API production lines.
Contract manufacturing of injectables, oral solutions, soluble powders, tablets, granules, and premixes.
Full-spectrum support including formulation development, analytical method development, stability studies, technology transfer, scale-up, commercial manufacturing, and process improvement.
Assistance with China market registration, customs clearance, warehousing, and international logistics for export to Africa.
Quality Commitment
All CMO partners are certified under China's GMP standards, with some holding additional international accreditations such as Australia APVMA and Philippines GMP, ensuring that products meet both Chinese regulatory requirements and the import standards of Kenya and other African markets.
Kenya Activities
The company is registered with the Kenya Veterinary Board (KVB) and the Veterinary Medicines Directorate (VMD), complying with local requirements for import, warehousing, and distribution of veterinary medicines under the Veterinary Medicines Directorate Regulations, 2015.
Registration for veterinary medicines, including products researched locally and outside Kenya.
Warehousing and cold-chain management for biologics and sensitive formulations.
Local sales, technical support, and veterinary training programs for farmers and animal health professionals.
Product Portfolio
Market & Growth Potential
The animal health market in Kenya presents promising investment opportunities, driven by increasing demand for veterinary products and services from a growing livestock industry. With Kenya's livestock sector contributing approximately 12% to national GDP, and national vaccine production targets doubling to 70 million doses by 2027, the market offers significant runway for growth.